{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:10:37Z","timestamp":1792548637745,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012526","name":"University of Aarhus Faculty of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009918","name":"Oda and Hans Svenningsen's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtha.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:28:44Z","timestamp":1737372524000},"page":"1367-1378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-9486","authenticated-orcid":false,"given":"Tua","family":"Gyldenholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Katballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Willy","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Decker","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.01.002_bib1","first-page":"1","article-title":"Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy","volume":"30","author":"Marshall-Webb","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jtha.2025.01.002_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.thromres.2017.01.009","article-title":"Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial","volume":"151","author":"Khorana","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jth.13279","article-title":"Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis","volume":"14","author":"Di Minno","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jth.14004","article-title":"Effect of rosuvastatin on risk markers for venous thromboembolism in cancer","volume":"16","author":"Ades","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00595-021-02260-2","article-title":"Venous thromboembolism after esophagectomy for cancer: a systematic review of the literature to evaluate incidence, risk factors, and prophylaxis","volume":"52","author":"Theochari","year":"2022","journal-title":"Surg Today"},{"key":"10.1016\/j.jtha.2025.01.002_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejso.2021.11.119","article-title":"Surgical outcomes after totally minimally invasive Ivor Lewis esophagectomy. A systematic review and meta-analysis","volume":"48","author":"Casas","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtha.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.JAA.0001007328.84376.da","article-title":"Esophageal cancer: treatment advances and need for screening","volume":"37","author":"Eisner","year":"2024","journal-title":"JAAPA"},{"key":"10.1016\/j.jtha.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jtcvs.2022.05.041","article-title":"Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery","volume":"165","author":"Shargall","year":"2023","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib10","author":"Rasmussen"},{"key":"10.1016\/j.jtha.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0044-1779672","article-title":"Risk of venous thromboembolism by cancer type: a network meta-analysis","volume":"50","author":"Betts","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"S963","DOI":"10.21037\/jtd.2018.04.70","article-title":"European perspectives in thoracic surgery, the ESTS venous thromboembolism (VTE) working group","volume":"10","author":"Shargall","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtha.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s11605-023-05815-5","article-title":"Can risk-based thromboprophylaxis practice guidelines be safely used in esophagectomy cases? Experience of an academic health system","volume":"27","author":"Edwards","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.1993.tb03218.x","article-title":"Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery","volume":"85","author":"Falanga","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1\u00a0+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1078-0432.CCR-14-3358","article-title":"Soluble vascular endothelial growth factor (sVEGF) and the risk of venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"22","author":"Posch","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtha.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.13218","article-title":"Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment","volume":"14","author":"Reitter","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/neuonc\/nou106","article-title":"Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas","volume":"16","author":"Thaler","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jtha.2025.01.002_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0043-1775856","article-title":"Thrombin generation markers as predictors of cancer-associated venous thromboembolism: a systematic review","volume":"50","author":"Gyldenholm","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.01.002_bib21","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A\u00a0modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jtha.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV study","volume":"22","author":"Cella","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jtha.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A\u00a0clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A\u00a0predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the Prospective COMPASS-Cancer-Associated Thrombosis Study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jtha.2025.01.002_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis risk assessment as a guide to quality patient care","volume":"51","author":"Caprini","year":"2005","journal-title":"Dis Mon"},{"key":"10.1016\/j.jtha.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.athoracsur.2015.05.098","article-title":"Evaluation of the Caprini model for venothromboembolism in esophagectomy patients","volume":"100","author":"Hewes","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s13063-024-08408-y","article-title":"Thromboprophylaxis in oesophageal cancer patients-a study protocol for a randomised, controlled trial (TOP-RCT)","volume":"25","author":"Gyldenholm","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jtha.2025.01.002_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2019.12.018","article-title":"Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients","volume":"186","author":"Lundbech","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.01.002_bib30","year":"2021","journal-title":"Definitions"},{"key":"10.1016\/j.jtha.2025.01.002_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjmed.2015.10.027","article-title":"Assessing the Caprini score for risk assessment of venous thromboembolism in hospitalized medical patients","volume":"129","author":"Grant","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1373\/clinchem.2012.182550","article-title":"Quantifying the added value of a diagnostic test or marker","volume":"58","author":"Moons","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtha.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jtha.2025.01.002_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.thromres.2018.07.009","article-title":"Prevalence of venous thromboembolism following head and neck cancer surgery: a systematic review and meta-analysis","volume":"169","author":"Lundbech","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.01.002_bib35","first-page":"1158","article-title":"Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial","volume":"7","author":"Song","year":"2015","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtha.2025.01.002_bib36","doi-asserted-by":"crossref","first-page":"e066785","DOI":"10.1136\/bmj-2021-066785","article-title":"Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials","volume":"376","author":"Marcucci","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.01.002_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/bjs.11665","article-title":"Thromboembolic and bleeding complications in patients with oesophageal cancer","volume":"107","author":"Mulder","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib38","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/bloodadvances.2020001804","article-title":"Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial","volume":"4","author":"Zwicker","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/onco.13540","article-title":"D-dimer enhances risk-targeted thromboprophylaxis in ambulatory patients with cancer","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jtha.2025.01.002_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/rth2.12161","article-title":"Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: an observational cohort study","volume":"3","author":"Chalayer","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.002_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000508271","article-title":"Evaluation of biomarkers for the prediction of venous thromboembolism in\u00a0ambulatory cancer patients","volume":"43","author":"Schorling","year":"2020","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jtha.2025.01.002_bib42","author":"Shulze"},{"key":"10.1016\/j.jtha.2025.01.002_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-022-01259-7","article-title":"A\u00a0new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study","volume":"15","author":"Tsubata","year":"2022","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jtha.2025.01.002_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jso.25800","article-title":"Development of a model predicting the risk of eight major postoperative complications after esophagectomy based on 10 826 cases in the Japan National Clinical Database","volume":"121","author":"Ohkura","year":"2020","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jtha.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/SLA.0000000000003500","article-title":"Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis","volume":"274","author":"Sakamoto","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib46","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.21037\/jtd-23-462","article-title":"Safe and efficient 2-step implementation of totally minimally invasive esophagectomy","volume":"15","author":"Lading","year":"2023","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtha.2025.01.002_bib47","first-page":"160","article-title":"Emergent esophagectomy in patients with esophageal malignancy is associated with higher rates of perioperative complications but no independent impact on short-term mortality","volume":"57","author":"Alwatari","year":"2024","journal-title":"J\u00a0Chest Surg"},{"key":"10.1016\/j.jtha.2025.01.002_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MBC.0000000000000315","article-title":"Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications","volume":"26","author":"Undas","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.01.002_bib49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:21:03Z","timestamp":1774254063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362500008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S153878362500008X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}